Abeona Therapeutics Shares Rise After Underwritten Offering Gets Priced
By Dean Seal Shares of Abeona Therapeutics jumped after the company's underwritten offering was priced to raise $75 million. The stock was up 21% at $4.92 ...
Abeona Prices Offering Of $75 Mln Common Stock, Warrants
Abeona Therapeutics Inc. (ABEO) announced Friday the pricing of an underwritten offering of 12,285,056 shares of its common stock and ...
Abeona shares tumble as FDA declines to approve skin disorder treatment
Abeona Therapeutics said on Monday the U.S. health regulator had declined to approve its treatment for a rare skin blistering ...
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CLEVELAND, May 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABEO) (“Abeona” or the “Company”) today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock and, in lieu of ...
Abeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not Lost
Abeona Therapeutics stock dropped by over half after receiving a CRL from FDA regarding its BLA for pz-cel. Find out why ABEO ...
BioSpace13d
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data
The regulator on Monday slapped Abeona Therapeutics with a Complete Response Letter for its investigational cell therapy ...
Seeking Alpha3d
Buying The Dip In Abeona Therapeutics After The Recent Manufacturing-Related CRL
Abeona Therapeutics (NASDAQ:ABEO) is a gene therapy company based in Cleveland, Ohio. The company's lead product candidate is Pz-cel, a gene therapy for recessive epidermolysis bullosa ...
Abeona Therapeutics Provides Regulatory Update on Pz-cel
Receives FDA Complete Response Letter (CRL) based on need for additional CMC information CRL did not identify deficiencies ...
FiercePharma12d
Another delay for Abeona's topical gene therapy pz-cel as FDA sends out a rejection
Abeona had hoped that a meeting with FDA on March 21 and commitments to provide CMC data before the PDUFA date and ...
Abeona Therapeutics Shares Down 53% After FDA Complete Response Letter
By Josh Beckerman Abeona Therapeutics shares fell 53%, to $3.45, after hours as its application for pz-cel received a Complete Response Letter from the ...
Nasdaq3d
Abeona Prices Offering Of $75 Mln Common Stock, Warrants
(RTTNews) - Abeona Therapeutics Inc. (ABEO) announced Friday the pricing of an underwritten offering of 12,285,056 shares of its common stock and pre-funded warrants to purchase 6,142,656 shares ...